Pricing Log in Create free account

Kyntra Bio Inc (KYNB) vs Quantum Biopharma Ltd. (QNTM)

Kyntra Bio Inc and Quantum Biopharma Ltd. are both Biotechnology companies. Kyntra Bio Inc and Quantum Biopharma Ltd. are of similar size ($21.9M and $21.7M). Quantum Biopharma Ltd. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Kyntra Bio Inc leads on 9 and Quantum Biopharma Ltd. on 4.

Valuation

Metric KYNB QNTM Biotechnology median
P/E 0.11 n/m 8.50
P/S 4.25 70.87 9.71
P/B n/m 2.70 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 16.35 28.83 9.21
Earnings yield 934.02% (222.27%) (33.15%)
Free cash flow yield (194.02%) (55.14%) (25.50%)

Profitability

Metric KYNB QNTM Biotechnology median
Gross margin 6.28% 0.00% 65.16%
Operating margin (1,089.78%) 0.00% 0.00%
Net margin 3,967.77% 0.00% 0.00%
Free cash flow margin (824.19%) 0.00% 0.00%
Return on equity (157.83%) (618.06%) (56.36%)
Return on assets 131.26% (169.48%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KYNB QNTM Biotechnology median
Revenue growth (TTM) (37.15%) — 6.02%
EPS growth (last fiscal year) 478.08% 37.50% 30.26%
Revenue growth, 5-year CAGR (48.42%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KYNB QNTM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.69 1.20 4.72
Net debt to EBITDA 1.97 0.31 0.96

Dividend

Metric KYNB QNTM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KYNB QNTM Biotechnology median
Market cap 21.70m 21.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack